Incidence and Clinical Outcome of Patients with Teratoma in the Retroperitoneum Following Primary Retroperitoneal Lymph Node Dissection for Clinical Stages I and IIA Nonseminomatous Germ Cell Tumors
- 1 October 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 170 (4 Part 1) , 1159-1162
Abstract
Purpose: We determined the incidence and clinical outcome of patients with clinical stages I and IIA nonseminomatous germ cell tumors (NSGCT), and teratoma in the retroperitoneum following ...Keywords
This publication has 14 references indexed in Scilit:
- RISK ADAPTED MANAGEMENT WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH RISK CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TUMORJournal of Urology, 2000
- Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumorsCancer, 1998
- CLINICAL STAGE I TESTIS CANCER: LONG-TERM OUTCOME OF PATIENTS ON SURVEILLANCEJournal of Urology, 1998
- TERATOMA WITH MALIGNANT TRANSFORMATION: DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM CELL TUMORSJournal of Urology, 1998
- Late relapse of germ cell tumors after cisplatin-based chemotherapyAnnals of Oncology, 1997
- Teratoma in the Orchiectomy Specimen and Volume of Metastasis are Predictors of Retroperitoneal Teratoma in Low Stage Nonseminomatous Testis CancerJournal of Urology, 1996
- Nonseminomatous germ cell tumors of the testis: Current concepts and controversiesUrology, 1994
- Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.Journal of Clinical Oncology, 1990
- Teratoma Following Cisplatin-Based Combination Chemotherapy for Nonseminomatous Germ Cell Tumors: A Clinicopathological CorrelationJournal of Urology, 1986
- The growing teratoma syndromeCancer, 1982